Team CHM will be participating in the 2021 TCS New York City Marathon to raise funds for the Choroideremia Research Foundation (CRF) on November 7, 2021.

Choroideremia (CHM) is a rare inherited retinal disorder that affects 1 in 50,000 individuals and causes progressive vision loss, ultimately leading to complete blindness. There currently are no treatment options or a cure for CHM. Funds raised will support choroideremia research and education.

* Please note that registering to be a fundraiser does not provide entry into the 2021 TCS New York City Marathon. Registration through this page is for fundraising purposes only.  

If you have questions, please contact us at info@curechm.org for assistance.